Evaluating the Effects of Adjunctive Aripiprazole on Weight and Metabolic Outcomes in Females

NCT06590298 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Psychosis
Metabolic Syndrome
Weight Gain

Interventions

DRUG: Adjunctive Aripiprazole for improving Weight and Metabolic Outcomes in Females

Sponsor

Universiti Putra Malaysia